Pilot study on the effects of dietary conjugated linoleic acid on tumorigenesis and gene expression in PyMT transgenic mice

Carcinogenesis

Volumn 31, Issue 9, 2010, Pages 1642-1649

  Flowers, Margaret ^a   Schroeder, Joyce A ^b   Borowsky, Alexander D ^c   Besselsen, David G ^d   Thomson, Cynthia A ^e   Pandey, Ritu ^f   Thompson, Patricia A ^f  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b The University of Arizona   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CONJUGATED LINOLEIC ACID; FORMALDEHYDE; PARAFFIN; RNA; UVOMORULIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INCIDENCE; CANCER INVASION; CANCER SIZE; CARCINOGENESIS; CELL ADHESION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENOTYPE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MAMMARY GLAND; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PILOT STUDY; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; STROMA; TRANSGENIC MOUSE; TUMOR PROMOTION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BLOTTING, WESTERN; CELL PROLIFERATION; DIET; FEMALE; GENE EXPRESSION PROFILING; IMMUNOENZYME TECHNIQUES; LINOLEIC ACIDS, CONJUGATED; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PILOT PROJECTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 77956285064     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq148     Document Type: Article

References (51)

1. National Cancer Institute USA. (2008) National Cancer Institute Factbook. http://www.cancer.gov/cancertopics/types/breast.
2. Geller,B.A. et al. (2005) Chemoprevention of breast cancer in postmenopausal women. Breast Dis., 24, 79-92.
3. Ip,C. et al. (1994) Conjugated linoleic acid. A powerful anticarcinogen from animal fat sources. Cancer, 74, 1050-1054.
4. Pariza,M.W. et al. (2001) The biologically active isomers of conjugated linoleic acid. Prog. Lipid Res., 40, 283-298.
5. MacDonald,H.B. (2000) Conjugated linoleic acid and disease prevention: a review of current knowledge. J. Am. Coll. Nutr., 19, 111S-118S.
6. Iversen,S.A. et al. (1984) Identification of a diene conjugated component of human lipid as octadeca-9,11-dienoic acid. FEBS Lett., 171, 320-324.
7. Parodi,P.W. (1976) Distribution of isomeric octadecenoic fatty acids in milk fat. J. Dairy Sci., 59, 1870-1873.
8. Kelley,N.S. et al. (2007) Conjugated linoleic acid isomers and cancer. J. Nutr., 137, 2599-2607.
9. Ip,C. et al. (1997) Retention of conjugated linoleic acid in the mammary gland is associated with tumor inhibition during the post-initiation phase of carcinogenesis. Carcinogenesis, 18, 755-759.
10. Ip,C. et al. (1994) Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res., 54, 1212-1215.
11. Ip,C. et al. (1999) Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J. Nutr., 129, 2135-2142.
12. Visonneau,S. et al. (1997) Conjugated linoleic acid suppresses the growth of human breast adenocarcinoma cells in SCID mice. Anticancer Res., 17, 969-973.
13. Maggiora,M. et al. (2004) An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines. Int. J. Cancer, 112, 909-919.
14. Kemp,M.Q. et al. (2003) Conjugated linoleic acid inhibits cell proliferation through a p53-dependent mechanism: effects on the expression of G1-restriction points in breast and colon cancer cells. J. Nutr., 133, 3670-3677.
15. Miglietta,A. et al. (2006) Conjugated linoleic acid induces apoptosis in MDA-MB-231 breast cancer cells through ERK/MAPK signalling and mitochondrial pathway. Cancer Lett., 234, 149-157.
16. Ip,M.M. et al. (2007) The t10, c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium. Carcinogenesis, 28, 1269-1276.
17. Meng,X. et al. (2008) t10, c12-Conjugated linoleic acid stimulates mammary tumor progression in Her2/ErbB2 mice through activation of both proliferative and survival pathways. Carcinogenesis, 29, 1013-1021.
18. Pochampalli,M.R. et al. (2007) Transforming growth factor alpha dependent cancer progression is modulated by Muc1. Cancer Res., 67, 6591-6598.
19. Folch,J. et al. (1957) A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem., 226, 497-509.
20. Sanders,S.R. et al. (2004) Effects of specific conjugated linoleic acid isomers on growth characteristics in obese Zucker rats. Lipids, 39, 537-543.
21. Lin,E.Y. et al. (2003) Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol., 163, 2113-2126.
22. Cardiff,R.D. et al. (2000) The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene, 19, 968-988.
23. Irizarry,R.A. et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249-264.
24. Breitling,R. et al. (2004) Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett., 573, 83-92.
25. Courtneidge,S.A. et al. (1983) Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature, 303, 435-439.
26. Guy,C.T. et al. (1994) Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev., 8, 23-32.
27. Webster,M.A. et al. (1998) Requirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell. Biol., 18, 2344-2359.
28. Cuevas,B.D. et al. (2006) MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer. Oncogene, 25, 4998-5010.
29. Oka,H. et al. (1992) Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch. A Pathol. Anat. Histopathol., 421, 149-156.
30. Murant,S.J. et al. (1997) Co-ordinated changes in expression of cell adhesion molecules in prostate cancer. Eur. J. Cancer, 33, 263-271.
31. Krishnadath,K.K. et al. (1997) Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J. Pathol., 182, 331-338.
32. Wu,X. et al. (2007) Cdc42 is crucial for the establishment of epithelial polarity during early mammalian development. Dev. Dyn., 236, 2767-2778.
33. Wu,X. et al. (2006) Cdc42 controls progenitor cell differentiation and betacatenin turnover in skin. Genes Dev., 20, 571-585.
34. Ou,L. et al. (2007) Conjugated linoleic acid induces apoptosis of murine mammary tumor cells via Bcl-2 loss. Biochem. Biophys. Res. Commun., 356, 1044-1049.
35. Masso-Welch,P.A. et al. (2002) Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid. Cancer Res., 62, 4383-4389.
36. Lim,D.Y. et al. (2005) Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21CIP1/WAF1. J. Cell. Physiol., 205, 107-113.
37. Kim,E.J. et al. (2006) trans-10, cis-12 conjugated linoleic acid inhibits the G1-S cell cycle progression in DU145 human prostate carcinoma cells. J. Med. Food, 9, 293-299.
38. Degner,S.C. et al. (2006) Conjugated linoleic acid attenuates cyclooxygenase-2 transcriptional activity via an anti-AP-1 mechanism in MCF-7 breast cancer cells. J. Nutr., 136, 421-427.
39. Lee,S.H. et al. (2006) Conjugated linoleic acid stimulates an antitumorigenic protein NAG-1 in an isomer specific manner. Carcinogenesis, 27, 972-981.
40. Moya-Camarena,S.Y. et al. (1999) Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J. Lipid Res., 40, 1426-1433.
41. Liu,J. et al. (2005) Anti-estrogenic effects of conjugated linoleic acid through modulation of estrogen receptor phosphorylation. Breast Cancer Res. Treat., 94, 161-169.
42. Miglietta,A. et al. (2006) Conjugated linoleic acid induces apoptosis in MDA-MB-231 breast cancer cells through ERK/MAPK signalling and mitochondrial pathway. Cancer Lett., 234, 149-157.
43. Cho,H.J. et al. (2003) Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line. Am. J. Physiol. Gastrointest. Liver Physiol., 284, G996-G1005.
44. Ip,C. et al. (1991) Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res., 51, 6118-6124.
45. Davol,P.A. et al. (2003) Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer. Cancer Res., 63, 6772-6783.
46. Park,Y. et al. (1997) Effect of conjugated linoleic acid on body composition in mice. Lipids, 32, 853-858.
47. Bocca,C. et al. (2007) Involvement of PPAR gamma and E-cadherin/betacatenin pathway in the antiproliferative effect of conjugated linoleic acid in MCF-7 cells. Int. J. Cancer, 121, 248-256.
48. Korner,A. et al. (2007) Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J. Clin. Endocrinol. Metab., 92, 1041-1048.
49. Mantzoros,C. et al. (2004) Adiponectin and breast cancer risk. J. Clin. Endocrinol. Metab., 89, 1102-1107.
50. Sotgia,F. et al. (2006) Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness. Am. J. Pathol., 168, 292-309.
51. Aresu,L. et al. (2008) Dog as model for down-expression of E-cadherin and b-catenin in tubular epithelial cells in renal fibrosis. Virchows Arch., 453, 617-625.